CSPC Pharmaceutical Group Limited (HKG:1093)
Hong Kong
· Delayed Price · Currency is HKD 8.36
-0.05 (-0.59%)
Apr 29, 2026, 4:08 PM HKT
CSPC Pharmaceutical Group Ratios and Metrics
Market cap in millions HKD. Fiscal year is January - December.
Millions HKD. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '26 Apr 28, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Market Capitalization | 95,580 | 96,380 | 55,169 | 86,022 | 97,707 | 100,932 | Upgrade
|
| Market Cap Growth | 50.30% | 74.70% | -35.87% | -11.96% | -3.19% | 6.47% | Upgrade
|
| Enterprise Value | 87,955 | 88,081 | 45,415 | 74,600 | 84,557 | 88,212 | Upgrade
|
| Last Close Price | 8.36 | 8.43 | 4.65 | 6.73 | 7.30 | 7.35 | Upgrade
|
| PE Ratio | 22.11 | 22.31 | 11.98 | 13.30 | 14.19 | 14.67 | Upgrade
|
| Forward PE | 13.05 | 17.08 | 9.76 | 12.05 | 13.86 | 15.70 | Upgrade
|
| PS Ratio | 3.30 | 3.33 | 1.79 | 2.48 | 2.79 | 2.95 | Upgrade
|
| PB Ratio | 2.49 | 2.51 | 1.53 | 2.23 | 2.73 | 3.07 | Upgrade
|
| P/TBV Ratio | 2.85 | 2.87 | 1.76 | 2.53 | 3.08 | 3.24 | Upgrade
|
| P/FCF Ratio | - | - | 20.58 | 30.56 | 15.99 | 25.49 | Upgrade
|
| P/OCF Ratio | - | - | 11.43 | 18.68 | 11.33 | 17.73 | Upgrade
|
| PEG Ratio | 1.01 | 1.96 | 1.10 | 1.30 | 0.76 | 1.25 | Upgrade
|
| EV/Sales Ratio | 3.04 | 3.04 | 1.47 | 2.15 | 2.42 | 2.58 | Upgrade
|
| EV/EBITDA Ratio | 15.83 | 15.69 | 6.62 | 8.53 | 9.83 | 10.31 | Upgrade
|
| EV/EBIT Ratio | 20.22 | 19.98 | 7.95 | 9.65 | 11.07 | 11.50 | Upgrade
|
| EV/FCF Ratio | - | - | 16.94 | 26.50 | 13.83 | 22.27 | Upgrade
|
| Debt / Equity Ratio | 0.02 | 0.02 | 0.02 | 0.02 | 0.02 | 0.00 | Upgrade
|
| Debt / EBITDA Ratio | 0.13 | 0.13 | 0.08 | 0.09 | 0.08 | 0.01 | Upgrade
|
| Debt / FCF Ratio | - | - | 0.20 | 0.28 | 0.11 | 0.03 | Upgrade
|
| Net Debt / Equity Ratio | -0.24 | -0.24 | -0.25 | -0.37 | -0.44 | -0.42 | Upgrade
|
| Net Debt / EBITDA Ratio | -1.63 | -1.63 | -1.34 | -1.65 | -1.84 | -1.61 | Upgrade
|
| Net Debt / FCF Ratio | - | - | -3.42 | -5.11 | -2.59 | -3.47 | Upgrade
|
| Asset Turnover | 0.57 | 0.57 | 0.64 | 0.71 | 0.81 | 0.86 | Upgrade
|
| Inventory Turnover | 2.78 | 2.78 | 2.78 | 3.26 | 3.45 | 3.10 | Upgrade
|
| Quick Ratio | 1.85 | 1.85 | 1.95 | 2.32 | 2.39 | 2.47 | Upgrade
|
| Current Ratio | 2.19 | 2.19 | 2.27 | 2.63 | 2.67 | 2.81 | Upgrade
|
| Return on Equity (ROE) | 11.33% | 11.33% | 12.60% | 18.22% | 21.32% | 22.79% | Upgrade
|
| Return on Assets (ROA) | 5.44% | 5.44% | 7.40% | 9.96% | 11.04% | 12.05% | Upgrade
|
| Return on Invested Capital (ROIC) | 12.29% | 12.39% | 17.69% | 29.11% | 33.40% | 34.94% | Upgrade
|
| Return on Capital Employed (ROCE) | 10.80% | 10.80% | 15.40% | 19.40% | 20.60% | 22.70% | Upgrade
|
| Earnings Yield | 4.52% | 4.48% | 8.35% | 7.52% | 7.05% | 6.82% | Upgrade
|
| FCF Yield | - | - | 4.86% | 3.27% | 6.26% | 3.92% | Upgrade
|
| Dividend Yield | 3.45% | 3.44% | 5.59% | 4.22% | 2.96% | 2.54% | Upgrade
|
| Payout Ratio | 63.47% | - | 74.72% | 46.42% | 34.42% | 30.16% | Upgrade
|
| Buyback Yield / Dilution | 2.68% | 2.68% | 1.14% | 0.38% | 0.29% | 0.01% | Upgrade
|
| Total Shareholder Return | 5.97% | 6.12% | 6.73% | 4.60% | 3.25% | 2.55% | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.